Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Asylia Therapeutics
AddedFeb 15, 2024
UpdatedJun 18, 2026
Asylia Therapeutics

Asylia Therapeutics

Asylia Therapeutics: A biotech firm innovating immune-modulating therapies for diverse diseases.

HQ
Houston, TX, US
Founded
2019
Overview
Compare
Fundraising
Employees
Website

Founded with a mission to transform scientific advances into safe and effective medicines, Asylia Therapeutics is a private development-stage biotechnology company. The company focuses on novel immune-modulating therapies targeting autoimmune diseases, cancer, and infectious diseases. Asylia's innovative platform centers on a drug pipeline designed to modulate antigen presentation to the immune system, aiming to produce unprecedented anti-tumor responses and other therapeutic benefits.

Asylia Therapeutics has attracted notable investors and key figures in the biotech industry, contributing to its rapid progress and recognition. The company's achievements include significant advancements in their drug pipeline, demonstrating promising preclinical results in modulating immune responses. Asylia's impact lies in its potential to revolutionize treatment paradigms for challenging diseases, offering hope for more effective and targeted therapies.

Asylia Therapeutics - Similar Companies

Asher Bio logo

Asher Bio

asherbio.com

Arialys Therapeutics logo

Arialys Therapeutics

arialysrx.com

Lapix Therapeutics logo

Lapix Therapeutics

lapix.com

Aristea Therapeutics logo

Aristea Therapeutics

Inimmune logo

Inimmune

inimmune.com

Halia Therapeutics logo

Halia Therapeutics

Fuse Biotherapeutics logo

Fuse Biotherapeutics

fusebiotx.com

Therabiol logo

Therabiol

LTZ Therapeutics logo

LTZ Therapeutics

Athos Therapeutics logo

Athos Therapeutics

athostx.com

Exalys Therapeutics logo

Exalys Therapeutics

Arisan Therapeutics logo

Arisan Therapeutics

arisanthera.com

Modulus Therapeutics logo

Modulus Therapeutics

Asalyxa Bio logo

Asalyxa Bio

ImmuneSensor Therapeutics logo

ImmuneSensor Therapeutics

immunesensor.com

Asylia Therapeutics - Quick Facts

Who are Asylia Therapeutics' competitors?

Companies similar to Asylia Therapeutics include Asher Bio, Arialys Therapeutics, Lapix Therapeutics and Aristea Therapeutics.

When was Asylia Therapeutics founded?

Asylia Therapeutics was founded in 2019.

Where is Asylia Therapeutics' headquarters located?

Asylia Therapeutics' headquarters is located in Houston, TX, US.

When was Asylia Therapeutics' last funding round?

Asylia Therapeutics' most recent funding round was for $14.5M (USD) in May 2021.

How much has Asylia Therapeutics raised to-date?

As of May 25, 2021, Asylia Therapeutics has raised a total of $22.7M (USD).

How many employees does Asylia Therapeutics have?

Asylia Therapeutics has 8 employees as of Feb 5, 2024.

Asylia Therapeutics - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Immune Therapies
Tags
  • Biotech
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified